Overview

A Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High Risk Surgery

Status:
Terminated

Trial end date:
2014-05-01

Target enrollment:

Participant gender:

Summary

This study will evaluate the safety and efficacy of ABT-719 in patients undergoing high risk major surgery.

Phase:

Phase 2

Details

Lead Sponsor:

AbbVie